COVID-19 Clinical Trials

Showing 841-860 of 1,603 trials

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

NCT04681001

This is a prospective, randomized placebo-controlled double blinded clinical trial in frontline healthcare workers managing COVID-19 patients. Participants will be weekly tested for SARS-CoV-2 and a panel of respiratory viruses. Treatment will be 3times a day for 84 days one puff into each nostirl and 3 puffs into mouth. Daily a symptom score will be recorded. The primary objective of the trial is to demonstrate that prophylactic treatment of health care workers managing COVID-19 patients with iota-carrageenan reduces symptoms of SARS-CoV-2 infections as well as infections with other respiratory viruses when compared to a placebo-treated control group.

Respiratory Viral InfectionCommon ColdSevere Acute Respiratory Syndrome (SARS) Pneumonia+2 more

Marinomed Biotech AG300 participantsStarted Dec 2020

Vienna, Austria • Vienna, Austria

COMPLETED

SARS-CoV-2 (Covid-19) RBD Antibody in My Duc Hospital Healthcare Workers

NCT05057910

To evaluate the immune response to the ChAdOx1 nCoV-19 vaccine by measuring the titers of antibody against the SARS-CoV-2 spike protein receptor binding domain (RBD) among healthcare workers of My Duc Hospital and investigate potential associations of vaccine protection against infection in this population. The study's data can suggest the groundwork for the development of predictive models for post-vaccination protection in the Vietnamese population as well as for establishing vaccination strategies to control disease outbreaks in the future.

Covid19Vaccine Reaction

Mỹ Đức Hospital645 participantsStarted Sep 2021

Ho Chi Minh City, Tan Binh, Vietnam

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

SARS-CoV-2 (Covid-19) RBD Antibody in My Duc Hospital Healthcare Workers

Related Searches

Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic

Rehabilitation for Post-COVID-19 Syndrome Through a Supervised Exercise Intervention

Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake

Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers

Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)

COVID-19, Obesity and Lifestyle in Children - Role of Professionals

Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19)

Hexoskin Feasibility Study With COVID-19 Patients

Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)

A Real-world Study to Evaluate the Safety and Immunogenicity of a Third-dose Booster After Two Doses of an Inactivated COVID-19 Vaccine

Treatment for COVID-19 in High-Risk Adult Outpatients

Antibodies and Immunity After Vaccination of Recovered Patients With COVID-19 and Long COVID-19 Symptoms

Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients

A Real-world Retrospective Study of Disease Outcomes in Non-severe COVID-19 Patient

Awake Prone Positioning in COVID-19 Suspects With Hypoxemic Respiratory Failure

Efficacy and Safety of Mucoadhesive Sustained Release, Mucodentol, in Comparison With Hydroxychloroquine to Prevent COVID-19

HLA-G Immuno-Inhibitor Checkpoint Study in Patients With COVID-19 Infection: Molecular and Cellular Assessment

Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults